Clinical trial
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US)
NCT04225806 is registered in ClinicalTrials.gov with Intervene, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US)
- Lead sponsor
- Intervene, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 13, 2020
- Completion date
- September 30, 2023
- Enrollment
- 15 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
chronic venous insufficiency (cvi), deep vein reflux